Intravenously Infused Stem Cells Show Promise in Heart Failure Intravenously Infused Stem Cells Show Promise in Heart Failure

Umbilical cord mesenchymal stem cells can be safely administered by intravenous infusion and significantly improve left-ventricular function and quality of life in patients with stable heart failure and reduced ejection fraction (HFrEF), according to results from the phase 1/2 RIMECARD trial.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Internal Medicine News Source Type: news